PionEar Technologies, Inc. is a bio-inspired platform medical device company revolutionizing the biomaterial design of conduit-like implants for drainage and drug delivery to different parts of the human body. The conduit technology -- PionEar -- features unique designs, generated by proprietary algorithms, and biocompatible super-repellent materials that prevent cells, pathogens, and biofluids from adhering to the surface, and provide a friction-free conduit for targeted drug delivery. The firm's first product - a patent-pending tympanostomy tube (commonly known as an ear tube) - is designed/intended to improve outcomes of patients with chronic ear infections. Overthe longer haul, management's longer-term vision is to commercialize a portfolio of first-of-its-kind medical conduits that synergistically reduce the risk of unnecessary revision surgeries, complications, and infections, worldwide. The firm's products are designed and intended to enable more efficacious drainage of biological fluids, and to maximize the therapeutic benefit of topical drug delivery. The conduit technology PionEar features unique designs, generated by proprietary algorithms, and biocompatible super-repellent materials that prevent cells, pathogens, and biofluids from adhering to the surface, and provide a friction-free conduit for targeted drug delivery. With its first product - a patent-pending tympanostomy tube (commonly known as an ear tube) - PionEar Technologies will improve outcomes of patients with chronic ear infections.
